Prebiotics, probiotics, fermented foods and cognitive outcomes: A meta-analysis of randomized controlled trials.


Journal

Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090

Informations de publication

Date de publication:
11 2020
Historique:
received: 03 12 2019
revised: 15 06 2020
accepted: 27 07 2020
pubmed: 30 8 2020
medline: 22 6 2021
entrez: 30 8 2020
Statut: ppublish

Résumé

This systematic review and meta-analysis aimed to evaluate randomized controlled trials that investigated the use of probiotic, prebiotic, and fermented food interventions for cognitive performance. In total, 22 studies (n = 1551) were included that investigated probiotics (11 studies, n = 724), prebiotics (5 studies, n = 355), and fermented foods (6 studies, n = 472). Despite several individual studies (14 of 22) reporting significant improvements in specific cognitive domains, results of the pooled meta-analysis found no significant effect for any intervention for global cognition (Probiotics: g = 0.115, 95 %CI -0.041, 0.270, p = 0.148; Prebiotics: g = 0.077, 95 %CI -0.091, 0.246, p = 0.369; Fermented food: g = 0.164 95 %CI -0.017, 0.345, p = 0.076) or any individual cognitive domain. Most studies (16 of 22) had low risk of bias. These results do not support the use of probiotic, prebiotic, and fermented food interventions for cognitive outcomes. This may be due to the limited number of small and short-term studies as well clinical heterogeneity relating to the population, cognitive tests, and intervention. Therefore, further trials that investigate these interventions in clinical populations using adequately powered samples are warranted. PROSPERO: CRD42019137936.

Identifiants

pubmed: 32860802
pii: S0149-7634(20)30505-4
doi: 10.1016/j.neubiorev.2020.07.036
pii:
doi:

Substances chimiques

Prebiotics 0

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

472-484

Subventions

Organisme : Medical Research Council
ID : MR/T021780/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Wolfgang Marx (W)

Deakin University, iMPACT, School of Medicine, Geelong, Australia. Electronic address: wolf.marx@deakin.edu.au.

Andrew Scholey (A)

Centre for Human Psychopharmacology, Swinburne University, VIC 3122, Australia.

Joseph Firth (J)

NICM Health Research Institute, Western Sydney University, Westmead, Australia; Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Nathan M D'Cunha (NM)

Faculty of Health, University of Canberra, Bruce, ACT 2601, Australia.

Melissa Lane (M)

Deakin University, iMPACT, School of Medicine, Geelong, Australia.

Meghan Hockey (M)

Deakin University, iMPACT, School of Medicine, Geelong, Australia.

Melanie M Ashton (MM)

Deakin University, iMPACT, School of Medicine, Geelong, Australia.

John F Cryan (JF)

APC Microbiome Ireland, University College Cork, Cork, Ireland; Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland.

Adrienne O'Neil (A)

Deakin University, iMPACT, School of Medicine, Geelong, Australia; Melbourne School of Population and Global Health, University of Melbourne, Australia.

Nenad Naumovski (N)

Faculty of Health, University of Canberra, Bruce, ACT 2601, Australia.

Michael Berk (M)

Deakin University, iMPACT, School of Medicine, Geelong, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Australia.

Olivia M Dean (OM)

Deakin University, iMPACT, School of Medicine, Geelong, Australia.

Felice Jacka (F)

Deakin University, iMPACT, School of Medicine, Geelong, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH